Invokana

Indicated For

Type 2 Diabetes

About This Medication

# Johnson & Johnson Patient Assistance Program Patient Guide: How to Get Invokana at Low or No Cost Invokana (canagliflozin) is a prescription medication used to help manage **type 2 diabetes** in adults by lowering blood sugar levels, reducing the risk of heart attack or stroke in certain patients, and aiding in kidney protection.[1][2] The **Johnson & Johnson Patient Assistance Program**, offered through Janssen, provides eligible patients with Invokana at **no cost** for up to one year if you meet income and other requirements.[1][4] ## Who Qualifies for the Program? This program helps patients who are **uninsured** or have insurance (commercial, employer-sponsored, or government coverage) that **does not fully meet their needs**.[1][8] You must reside in the **United States or Puerto Rico** and have a valid prescription from a U.S.-licensed healthcare provider.[6][8] Importantly, the program targets those facing **access and affordability challenges**.[8] **Key eligibility factors include:** - Residency: U.S. or Puerto Rico. - Prescription: For outpatient use, signed by your doctor.[3] - Income: Must meet program guidelines (detailed below).[1] - Insurance status: Uninsured or underinsured.[1][8] Patients with **Medicare Part D** may qualify if they spend more than **4% of gross annual household income** on prescriptions and are not eligible for Low-Income Subsidy (LIS), especially if income is ≤150% FPL.[3][6] ## About Invokana (Canagliflozin) Invokana belongs to a class of drugs called **SGLT2 inhibitors**. It works by helping your kidneys remove excess sugar from your blood through urine, which lowers blood sugar without causing significant weight gain or low blood sugar when used alone.[1][2] It's typically taken once daily before the first meal of the day. **Common uses:** - Improving blood sugar control in type 2 diabetes, alongside diet and exercise. - Reducing risk of major cardiovascular events (like heart attack or stroke) in patients with established cardiovascular disease. - Slowing kidney function decline in certain patients with type 2 diabetes and chronic kidney disease.[1] **Important safety notes:** Always follow your doctor's instructions. Invokana can increase risk of dehydration, yeast infections, or ketoacidosis. Contact your doctor for side effects like frequent urination, dizziness, or leg cramps.[1] This guide focuses on assistance, not medical advice—consult your healthcare provider. ## Income Eligibility Breakdown The program requires your household income to meet specific thresholds based on **Federal Poverty Level (FPL)** guidelines, though exact percentages vary and are not publicly detailed here.[1][6] Income is assessed for your household size using documents like your most recent **1040 or 1040-SR tax return**.[2] For Puerto Rico residents, additional financial documentation (e.g., Form 482 or AS 6088.1) is required.[2] Here's a general **income eligibility table** (contact the program for your exact situation, as thresholds adjust annually): | Household Size | Approximate Max Income (e.g., <400-500% FPL)* | |----------------|---------------------------------------------| | 1 (Individual) | Up to ~$60,000-$75,000 | | 2 (Couple) | Up to ~$80,000-$100,000 | | 3 | Up to ~$100,000-$125,000 | | 4 | Up to ~$120,000-$150,000 | *Estimates based on typical PAP structures; **call (833) 742-0791** for precise, current FPL-based limits. Larger families get higher thresholds.[1][2][6] ## Insurance Requirements - **Uninsured patients**: Fully eligible if other criteria met.[1][9] - **Insured patients**: Eligible if coverage (commercial, employer, Medicare/Medicaid) leaves you with high out-of-pocket costs.[1][8] - **Medicare Part D**: Submit proof of >4% income spent on drugs; EOB or pharmacy reports may be needed.[3][8] The program does **not cover** treatment administration costs—only the medication.[8] ## Step-by-Step Application Process 1. **Gather documents**: Proof of income (tax return), residency (e.g., utility bill), prescription, insurance cards (front/back if applicable).[1][2] 2. **Download/complete forms**: Get the **Patient Assistance Enrollment Form** from JJPatientAssistance.com. You and your doctor complete/sign it (page 3 for prescription).[2][3] 3. **Sign consents**: Review and sign Patient Consent and Authorization Forms (pages 4-7 or online at JJPatientAssistance.com/Consent and /PA).[2] 4. **Choose method**: - **Online**: Upload at portal.jnjwithme.com/patient-assistance/enroll.[1] - **Phone**: Call **(833) 742-0791** (Mon-Fri, 8 AM-8 PM ET) for help.[2][3] - **Fax**: Send to 833-512-0497.[3][8] 5. **Submit**: Include all docs to avoid delays.[2] Your doctor must provide prescription details.[3] ## Timeline and Delivery Processing time varies (typically **2-4 weeks**), but incomplete apps delay approval.[2] You'll get status updates via phone/email.[3] If approved, Invokana is **shipped free** to your home or doctor's office for up to **12 months**.[1][4][6] **Reauthorization** is required annually—reapply before supply ends.[1][6] ## Alternatives if Denied or Ineligible - **Reapply** with updated docs.[2] - **Medicine Assistance Tool (MAT)**: Search MAT.org for other programs.[5] - **JJPAF**: Separate nonprofit for uninsured (JJPAF.org or 800-652-6227).[9] - **Simplefill**: Helps navigate applications (877-386-0206).[6] - **Janssen CarePath**: Savings cards for commercially insured (MyJanssenCarePath.com).[9] - Generic/biosimilar options: None currently listed for Invokana.[program data] Contact the program for denial reasons and next steps.[3] ## Disclaimer This guide is for informational purposes only and based on available program details as of general knowledge.[1][2] Eligibility, terms, and income limits can change—**always verify directly** with Johnson & Johnson Patient Assistance Program at (833) 742-0791 or JJPatientAssistance.com. Not medical or legal advice. Consult your doctor for treatment decisions. Program provides medication only; no guarantees of approval.

Program information last verified: March 30, 2026